Deep Bio and PathAI Collaborate to Drive AI-Powered Innovations in Digital Pathology
recent articles
Dublin, 16th September 2024 — Deciphex today announced the launch of VICT3R, a groundbreaking initiative aimed at transforming nonclinical drug and chemical safety evaluation. VICT3R is a public-private partnership supported by the...
Nijmegen, the Netherlands – Aiosyn is proud to announce the first results of an independent clinical performance study conducted for its Aiosyn Mitosis Breast solution. This study was performed at Radboud University Medical Center...
NIJMEGEN, the Netherlands – Aiosyn, a pioneering pathology software company specializing in AI-powered solutions for kidney disease and breast cancer, has integrated its glomerular quantification algorithm with Sectra’s diagnostic...
From Deciphex on LinkedIn: 🚨 Don’t Miss Our Upcoming Webinar! 🚨 Join us for the second webinar in our series with Charles River Laboratories, where we’ll reveal the results of a time and motion study on Patholytix Foresight!...
AP-HP has selected Aiforia as a partner for AI-assisted pathology i...
- Anatomic Pathology
- Artificial Intelligence
- Clinical Laboratories
- Cloud Computing
- Current Affairs
- Data Management
- Digital Pathology News
- Education
- Government
- Image Analysis
- Informatics
- International
- Laboratory Informatics
- Medical Research
- New Digital Imaging Technologies
- Pathology News
- Press Release
- Training
- Vendor products
- Web/Tech
- Whole slide
Assistance Publique–Hôpitaux de Paris (AP-HP) has selected Aiforia Technologies Plc as a partner for AI-assisted pathology image analysis in clinical diagnostics. The collaboration involves the use of the Aiforia Clinical AI solutions for...
Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine and improve cancer biomarker testing SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Lunit...
